News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

National Institutes of Health (NIH) To Start Ebola Vaccine Clinical Trials As Early As September



8/4/2014 6:47:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The USA will launch an early-stage trial in September of an experimental vaccine against Ebola, the deadly viral disease that has killed 729 people in the largest outbreak in history.

The National Institutes of Health has been developing an Ebola vaccine for several years that has had "encouraging results" in primates, says Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. Fauci said he's working with the Food and Drug Administration to fast track the vaccine into a phase 1 clinical trial this fall. This type of trial is the earliest study in humans and aims to make sure that drugs are safe and show some efficacy.

Help employers find you! Check out all the jobs and post your resume.

Read at USA Today
Read at ABC News


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES